Surviving crises
as filed1.7/10
Has it survived what it has been through?
6 warning events since 2022; the latest 2026-07-14.
weight 33% of this tense · 17th percentile among 9 sector filers · read for itself
From the record
SBC Medical Group Holdings Incorporated's filings since 2022 show 6 warning events of 3 kinds: a notice about its exchange listing (8-K item 3.01, 3 times, the latest 2026-07-14); an auditor change (8-K item 4.01, the latest 2024-09-20); a late-report notice (Form NT 10-K or NT 10-Q, 2 times, the latest 2024-08-14) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Track record
as filed3.4/10
What has it actually done, year after year?
-5.3% a year over 3 filed years; profitable in 3 of 3.
weight 45% of this tense · 34th percentile among 8 sector filers · read for its customers
From the record
SBC Medical Group Holdings Incorporated's 3 filed years say what it did: revenue went from $194 million in fiscal 2023 to $174 million in fiscal 2025, down 5.3% a year; it rose in 1 of 2 years; the deepest fall was 15% from fiscal 2024 to fiscal 2025; net income was positive in 3 of 3 of those years (its annual reports).
What it rests on
- revenue growth over the filed span-5.3%bottom 6% of its family
- the share of years revenue rosebottom 6% of its family
- the share of filed years with a profittop 6% of its family
- the deepest fall from a revenue peak15.5%bottom 31% of its family
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Shareholder treatment
as filed6.0/10
How has it treated the people who own it?
Share count grew 4.6% a year. 5% of cash flow returned. Insiders: 3 sales, 0 purchases.
weight 22% of this tense · 60th percentile among 6 sector filers · read for its shareholders
From the record
Over the 2 fiscal years to 2025-12-31, SBC Medical Group Holdings Incorporated's diluted share count grew about 4.6% a year, and dividends and buybacks returned about 5% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 3 sales and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).
What it rests on
- the share count over the yearstop 39% of its family
- cash returned against operating cash flowtop 42% of its family
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.